Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 13/20 | 0.41 |
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.41 |
| ▸ | KIF11 | P52732 | 1/20 | 0.40 |
| ▸ | F11 | P03951 | 2/20 | 0.35 |
| ▸ | F2 | P00734 | 1/20 | 0.34 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.34 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.34 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.34 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA3 | P07451 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1230718 | 0.81 | LPL (0.47) | LPLLIPGF11F2PRSS1 | |
| SCHEMBL15614863 | 0.80 | LPL (0.46) | LPLLIPGF11F2PRSS1 | |
| SCHEMBL12509747 | 0.79 | KIF11 (0.40) | KIF11 | |
| SCHEMBL24275668 | 0.79 | LPL (0.42) | LPLLIPGF11F2PRSS1 | |
| SCHEMBL20627954 | 0.78 | LPL (0.45) | LPLLIPGF11F2PRSS1 | |
| SCHEMBL15614858 | 0.76 | LPL (0.43) | LPLLIPGF11CA1CA2 | |
| SCHEMBL423133 | 0.73 | KIF11 (0.47) | KIF11 | |
| SCHEMBL16891264 | 0.71 | LPL (0.47) | LPLLIPGF11F2PRSS1 | |
| SCHEMBL29914599 | 0.71 | LPL (0.47) | LPLLIPGF11F2PRSS1 | |
| SCHEMBL23294563 | 0.71 | LPL (0.47) | LPLLIPGF11F2PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7976958-B2 | phosphorescence; tetrakis[2-(2,2,4,4-tetrafluoro-1,3-henzodioxan-6-yl)pyridine-C.sup.7,N](mu.-dichloro)diiridium(III) | CANON KABUSHIKI KAISHA (JP) | 2011-07-12 | — | — | US | disclosed |
| US-7976958-B2 | phosphorescence; tetrakis[2-(2,2,4,4-tetrafluoro-1,3-henzodioxan-6-yl)pyridine-C.sup.7,N](mu.-dichloro)diiridium(III) | CANON KABUSHIKI KAISHA (JP) | 2011-07-12 | — | — | US | disclosed |
| US-20080131730-A1 | METAL COMPLEX COMPOUND, ELECTROLUMINESCENT DEVICE AND DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2008-06-05 | — | — | US | disclosed |
| US-20080131730-A1 | METAL COMPLEX COMPOUND, ELECTROLUMINESCENT DEVICE AND DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2008-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080131730-A1 | METAL COMPLEX COMPOUND, ELECTROLUMINESCENT DEVICE AND DISPLAY APPARATUS | L1CAM, EMC1, EMC2 | LPL 406/4885LIPG 1332/4885KIF11 897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.